Supply Chain Archives
03/21/2025
Strengthening ATMP Development in Europe: How BioServices Centers in France Enable Efficiency and Scalability
As Advanced Therapy Medicinal Product (ATMP) developers progress from early-stage research to late-phase clinical trials and commercialization, biostorage, sample management, and regulatory-compliant logistics become increasingly complex. Efficiently managing these critical components is essential to ensure product integrity, regulatory compliance, and seamless supply chain operations.
03/21/2025
Optimizing ATMP Cryopreservation: How IntegriCell™ Services in Belgium Ensure Cell Viability and Supply Chain Integrity
Cryopreservation is quickly becoming a critical yet often underestimated component of the Advanced Therapy Medicinal Product (ATMP) supply chain. The success of cell-based therapies depends on maintaining cell viability, stability, and consistency, yet variability in cryopreservation methods has compromised therapeutic outcomes.
03/12/2025
Global Experts, Local Presence: Strengthening Europe’s Advanced Therapy Supply Chain
The development and commercialization of Advanced Therapy Medicinal Products (ATMPs) in Europe require a highly coordinated supply chain. From temperature-controlled logistics and biostorage to regulatory compliance, every stage of the ATMP lifecycle depends on precision, reliability, and risk mitigation
08/26/2024
3 Fundamental Services for Superior Master Cell Bank Management
The consistency of controlled conditions is vital throughout every step in producing advanced therapies, and the process usually begins with the secure handling and storage of the cells used for manufacturing.
07/16/2024
IntegriCell™: Extending Cell Viability with Manufacture-ready Cryopreserved Leukopaks
During the COVID-19 pandemic, the restrictions on transportation and travel negatively impacted patients' access to life-saving treatments and support.
06/27/2024
Cryoport Systems Celebrates Expanded French Facility with Ribbon Cutting Ceremony
Cryoport Systems commemorated the significant expansion of its Pont-du-Château facility in France with a ribbon cutting ceremony that officially launched the updated site.
04/16/2024
Overcoming Industry Obstacles for Cell and Gene Therapy Development
In the rapidly advancing world of cell and gene therapy (CGT) development, finding the proper solution to overcome common industry obstacles is a challenge that can impact entire production timelines.
04/09/2024
National Holiday Facility Closures
As we look to the rest of 2024, Cryoport Systems wants to ensure that you’re up to date on our service schedule.
02/06/2024
